Compounds > tretazicar

Page last updated: 2024-08-26

tretazicar and Cancer of Colon

tretazicar has been researched along with Cancer of Colon in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (12.50)	18.7374
1990's	2 (25.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	3 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dubois, L; Ehsaan, M; Heap, JT; Knox, R; Kubiak, AM; Kuehne, SA; Lambin, P; Minton, NP; Paesmans, K; Theys, J; Van Mellaert, L	1
Byrne, WL; Cummins, J; Lehouritis, P; McCarthy, FO; Murphy, CT; Reid, G; Stanton, M; Tangney, M; Urbaniak, C	1
Ackerley, DF; Copp, JN; Patterson, AV; Prosser, GA; Smaill, JB; Syddall, SP; Williams, EM; Wilson, WR	1
Chen, MJ; Fuerer, C; Iggo, R; Lukashev, AN; Searle, P	1
James, ND; Latham, JP; Mautner, V; Searle, PF	1
Sugget, N; Walton, MI; Workman, P	1
Baer, J; Bagshawe, KD; Sunters, A	1
Donaldson, J; Morgan, JE; Talbot, K; Twentyman, PR; Workman, P; Wright, KA	1

Other Studies

8 other study(ies) available for tretazicar and Cancer of Colon

Article	Year
Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo. Oncotarget, 2014, 04-15, Volume: 5, Issue:7 Topics: Animals; Antineoplastic Agents; Aziridines; Biological Therapy; Carcinoma; Clostridium; Colonic Neoplasms; Mice; Neisseria meningitidis; Nitroreductases; Organisms, Genetically Modified; Plasmids; Prodrugs; Protein Engineering; Spores, Bacterial; Xenograft Model Antitumor Assays	2014
Local bacteria affect the efficacy of chemotherapeutic drugs. Scientific reports, 2015, Sep-29, Volume: 5 Topics: Animals; Antineoplastic Agents; Aziridines; Biotransformation; Cladribine; Colonic Neoplasms; Deoxycytidine; Escherichia coli; Female; Gemcitabine; Injections, Intralesional; Injections, Subcutaneous; Listeria; Mice; Neoplasm Transplantation; Skin; Treatment Outcome; Vidarabine	2015
Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954. Biochemical pharmacology, 2010, Mar-01, Volume: 79, Issue:5 Topics: Adenocarcinoma; Antineoplastic Agents; Aziridines; Cell Survival; Colonic Neoplasms; Drug Screening Assays, Antitumor; Escherichia coli; Escherichia coli Proteins; Gene Silencing; Genetic Therapy; Humans; Kinetics; Nitroreductases; Prodrugs; SOS Response, Genetics; Transfection; Tumor Cells, Cultured	2010
Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954. Human gene therapy, 2005, Volume: 16, Issue:12 Topics: Adenoviridae; Animals; Antibiotics, Antineoplastic; Aziridines; Cell Line; Colonic Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Escherichia coli Proteins; Fibroblasts; Genetic Therapy; Genetic Vectors; Humans; Male; Mice; Mice, Nude; Nitroreductases; Oncolytic Viruses; Prodrugs; Sirolimus; Transduction, Genetic	2005
Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector. Cancer research, 2000, Jan-15, Volume: 60, Issue:2 Topics: Adenoviridae; Androgens; Antineoplastic Agents; Aziridines; Cell Survival; Colonic Neoplasms; Coloring Agents; Cytomegalovirus; Enhancer Elements, Genetic; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Jurkat Cells; Kinetics; Luciferases; Luminescent Proteins; Male; Oxazines; Polymerase Chain Reaction; Prodrugs; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Recombinant Fusion Proteins; Tissue Kallikreins; Transfection; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Xanthenes	2000
The role of human and rodent DT-diaphorase in the reductive metabolism of hypoxic cell cytotoxins. International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:4 Topics: Animals; Antineoplastic Agents; Aziridines; Carcinoma 256, Walker; Cell Hypoxia; Colonic Neoplasms; Humans; In Vitro Techniques; Indolequinones; Indoles; Mitomycin; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Prodrugs; Rats; Tirapazamine; Triazines	1992
Cytotoxicity and activation of CB1954 in a human tumour cell line. Biochemical pharmacology, 1991, May-01, Volume: 41, Issue:9 Topics: Animals; Antineoplastic Agents; Aziridines; Biotransformation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; NAD; Nitroreductases; Prodrugs; Tumor Cells, Cultured	1991
CB 1954 revisited. II. Toxicity and antitumour activity. Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:1 Topics: Animals; Aziridines; Azirines; Colonic Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Interactions; Humans; Lomustine; Mammary Neoplasms, Experimental; Melphalan; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Sarcoma, Experimental	1986